1. miR-21-5p is a Biomarker for Predicting Prognosis of Lung Adenocarcinoma by Regulating PIK3R1 Expression
   Jianting Du et al, 2021, International Journal of General Medicine CrossRef
2. Molecular subtypes based on cuproptosis-related genes and immune profiles in lung adenocarcinoma
   Yufei Wang et al, 2022, Frontiers in Genetics CrossRef
3. Identification and Validation a Necroptosis‑related Prognostic Signature and Associated Regulatory Axis in Stomach Adenocarcinoma
   Ning Wang et al, 2021, OncoTargets and Therapy CrossRef
4. Role of MicroRNA-21 in Prostate Cancer Progression and Metastasis: Molecular Mechanisms to Therapeutic Targets
   Vipendra Kumar Singh et al, 2024, Annals of Surgical Oncology CrossRef
5. MicroRNA21 inhibition affects porcine oocyte maturation and alters protein expression critical for metabolic pathway function
   Yunsheng Li et al, 2022, Molecular Reproduction and Development CrossRef
6. Interconnections within the tumor microenvironment: extracellular vesicles as critical players of metabolic reprogramming in tumor cells
   Carol Costa Encarnação et al, 2024, Journal of Cancer Metastasis and Treatment CrossRef
7. Alternative Splicing Events in Tumor Immune Infiltration in Colorectal Cancer
   Jian-yu Shi et al, 2021, Frontiers in Oncology CrossRef
8. Comprehensive bioinformatics analysis to identify a novel cuproptosis-related prognostic signature and its ceRNA regulatory axis and candidate traditional Chinese medicine active ingredients in lung adenocarcinoma
   Shaohui Wang et al, 2022, Frontiers in Pharmacology CrossRef
9. Insights into prognosis and immune infiltration of cuproptosis-related genes in breast cancer
   Tingting Huang et al, 2022, Frontiers in Immunology CrossRef
10. Effects of UBE3A on Cell and Liver Metabolism through the Ubiquitination of PDHA1 and ACAT1
    Kangli Peng et al, 2023, Biochemistry CrossRef
11. Pyruvate Dehydrogenase Contributes to Drug Resistance of Lung Cancer Cells Through Epithelial Mesenchymal Transition
    Buse Cevatemre et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
12. Progress in the research of cuproptosis and possible targets for cancer therapy
    Jiang Wang et al, 2023, World Journal of Clinical Oncology CrossRef
13. Effects of Intensive Fattening With Total Mixed Rations on Carcass Characteristics, Meat Quality, and Meat Chemical Composition of Yak and Mechanism Based on Serum and Transcriptomic Profiles
    Yi-Xuan Liu et al, 2021, Frontiers in Veterinary Science CrossRef
14. Identification of the prognostic signature based on genomic instability-related alternative splicing in colorectal cancer and its regulatory network
    Qiuying Ding et al, 2022, Frontiers in Bioengineering and Biotechnology CrossRef
15. Identification of cuproptosis-related genes for predicting the development of prostate cancer
    Xin’an Wang et al, 2023, Open Medicine CrossRef
16. A novel cuproptosis-related subtypes and gene signature associates with immunophenotype and predicts prognosis accurately in neuroblastoma
    Xiao-Mao Tian et al, 2022, Frontiers in Immunology CrossRef
17. Comprehensive analysis of cuproptosis-related genes in prognosis, tumor microenvironment infiltration, and immunotherapy response in gastric cancer
    Haihang Nie et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef
18. Endoplasmic Reticulum Stress-Related Four-Biomarker Risk Classifier for Survival Evaluation in Esophageal Cancer
    Xiang Xu et al, 2022, Journal of Oncology CrossRef
19. Cuproptosis and cuproptosis–related genes in rheumatoid arthritis: Implication, prospects, and perspectives
    Jianan Zhao et al, 2022, Frontiers in Immunology CrossRef
20. Comprehensive analyses of PDHA1 that serves as a predictive biomarker for immunotherapy response in cancer
    Langmei Deng et al, 2022, Frontiers in Pharmacology CrossRef
21. Integrative analysis revealed that distinct cuprotosis patterns reshaped tumor microenvironment and responses to immunotherapy of colorectal cancer
    Ximo Xu et al, 2023, Frontiers in Immunology CrossRef
22. Cuproptosis-a potential target for the treatment of osteoporosis
    Dinglin Li et al, 2023, Frontiers in Endocrinology CrossRef